Shire headache for FTSE

clock

Having charged across the 5,000 mark yesterday, the FTSE 100 index has shed a couple of points this morning to 4,987.7, paced by Shire Pharmaceuticals Group.

Drugmaker Shire has fallen 60.5p or as much as 9.5% to 581.50p, after Canadian regulators ordered the company to withdraw its biggest selling drug, Adderall XR, as a result of its link to at least 20 deaths. Barclays bank has also dropped 14p to 580p in morning trading even though the lender posted a 14% increase in second-half profit as investment-banking income rose and loan loss provisions declined. Imperial Chemical Industries meanwhile has gained 20.50p or 8% to 266.50p. In Japan the Nikkei 225 Stock Average raced to a seven-month high, advancing 0.7% to 11,553.56 at its close ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Chaos is not a ladder: Navigating human behaviour at times of market stress

Chaos is not a ladder: Navigating human behaviour at times of market stress

'It is important to maintain perspective'

Sacha Chorley
clock 09 March 2026 • 4 min read
Four reasons why direct engagement can still make a difference

Four reasons why direct engagement can still make a difference

'Quantitative data arguably tells only half the story'

Simon Wood
clock 05 March 2026 • 4 min read
Darius McDermott: Is income under pressure?

Darius McDermott: Is income under pressure?

‘The period of abundant income is ebbing'

Darius McDermott
clock 04 March 2026 • 5 min read